Publications by authors named "John Meijer"

Claim this Profile
W
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum.
Lee Goodwin, Jörg Faber, Kristina H Holmberg, Stuart McDougall, John Meijer

Bioanalysis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilocarpine-Induced Effects on Salivary Secretion as a Pharmacological Biomarker for Cholinergic Parasympathetic Activation.
Nicoline Treijtel, Dorien Groenendaal-van de Meent, Ingrid Michon, Cees Korstanje, John Meijer

Clin Pharmacol Drug Dev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device.
Nasrullah Undre, Imran Hussain, John Meijer, Johannes Stanta, Gordon Swan

Ther Drug Monit· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity.
Stacey Tannenbaum, Martin den Adel, Walter Krauwinkel, John Meijer, Adriana Hollestein-Havelaar

Pharmacol Res Perspect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects.
Masaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, Desiree van der Heide, John Meijer

Adv Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels.
Masaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, John Meijer

Adv Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of LC-MS/MS methods for the determination of mirabegron and eight metabolites in human plasma in a paediatric population.
John Meijer, Tom van den Berg, Robert Huls, Vincent Hofstede, Willem Niesing

J Pharm Biomed Anal· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of methionine-enkephalin and leucine-enkephalin by LC-MS in human plasma: Study of pre-analytical stability.
Aliye Ozalp, Begona Barroso, John Meijer, Cas van den Beld

Anal Biochem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects.
Marcel van Gelderen, Matthias Stölzel, John Meijer, Virginie Kerbusch, Christiane Collins

J Clin Pharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of control charts in regulated bioanalysis for monitoring long-term reproducibility.
Michel van Bruijnsvoort, John Meijer, Cas van den Beld

Bioanalysis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
Monique Groen-Wijnberg, Jan van Dijk, Walter Krauwinkel, Virginie Kerbusch, John Meijer

Eur J Drug Metab Pharmacokinet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men.
Marcel van Gelderen, Reiner Tretter, John Meijer, Caroline Dorrepaal, Shanti Gangaram-Panday

Int J Clin Pharmacol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol.
Walter Krauwinkel, James Dickinson, Marloes Schaddelee, John Meijer, Reiner Tretter

Eur J Drug Metab Pharmacokinet· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects.
Walter J J Krauwinkel, Virginie M M Kerbusch, John Meijer, Reiner Tretter, Gregory Strabach

Clin Pharmacol Drug Dev· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.
Jennifer Lee, Selina Moy, John Meijer, Walter Krauwinkel, Taiji Sawamoto

Clin Drug Investig· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron.
James Dickinson, Michaelene Lewand, Taiji Sawamoto, Walter Krauwinkel, Marloes Schaddelee, John Meijer

Clin Drug Investig· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
Charlotte Eltink, Jennifer Lee, Marloes Schaddelee, Wenhui Zhang, Virginie Kerbusch, John Meijer

Int J Clin Pharmacol Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
Walter Krauwinkel, Jan van Dijk, Marloes Schaddelee, Charlotte Eltink, John Meijer

Clin Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
Shin Takusagawa, Jan Jaap van Lier, Katsuhiro Suzuki, Masanori Nagata, John Meijer

Drug Metab Dispos· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of LC-MS/MS methods for the determination of mirabegron and its metabolites in human plasma and their application to a clinical pharmacokinetic study.
Raymond van Teijlingen, John Meijer, Shin Takusagawa, Marcel van Gelderen, Cas van den Beld

J Chromatogr B Analyt Technol Biomed Life Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
Marianne J Engelhart, Annemieke Ruitenberg, John Meijer, Amanda Kiliaan, John C van Swieten

Dement Geriatr Cogn Disord· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.
Marianne J Engelhart, Mirjam I Geerlings, John Meijer, Amanda Kiliaan, Annemieke Ruitenberg

Arch Neurol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory proteins and depression in the elderly.
Henning Tiemeier, Albert Hofman, H Ruud van Tuijl, Amanda J Kiliaan, John Meijer

Epidemiology· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study.
Henning Tiemeier, H Ruud van Tuijl, Albert Hofman, John Meijer, Amanda J Kiliaan

Am J Psychiatry· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion.
Eszter Farkas, Martijn C de Wilde, Amanda J Kiliaan, John Meijer, Jan N Keijser

Brain Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis